Birgitta Versluijs

Favorable outcome of untreated RSV infection in pediatric hematopoietic cell transplantation A.B. Versluys, T.E. Faber, J.J. Boelens, L.J. Bont Manuscript submitted Abstract Little is known about untreated respiratory syncytial virus (RSV) infection in pediatric hematopoietic cell transplan- tation (HCT). In 310 HCT-recipients, 8 children (3%) had RSV-infection, none received antiviral treatment, and none progressed to severe RSV-disease. These results support restrictive use of costly antivirals to prevent or treat RSV in pediatric HCT-recipients. Blood and Marrow Transplantation Program, Department of Pediatrics, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands A.B. Versluys J.J. Boelens Department of Pediatrics, Medical Center Leeuwar- den, Leeuwarden, The Netherlands T.E. Faber U-DANCE Laboratory of Translational Immunology, University Medical Center Utrecht, The Netherlands J.J. Boelens Department of Paediatric Infectious Diseases, UMCU, Wilhelmina Children's Hospital, Utrecht, The Netherlands L.J. Bont